| DC Field | Value | Language |
|---|
| dc.contributor.author | Deykin, A. V. | - |
| dc.contributor.author | Shcheblykina, O. V. | - |
| dc.contributor.author | Povetka, E. E. | - |
| dc.contributor.author | Golubinskaya, P. A. | - |
| dc.contributor.author | Pokrovsky, V. M. | - |
| dc.date.accessioned | 2022-05-11T11:27:41Z | - |
| dc.date.available | 2022-05-11T11:27:41Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Genetically modified animals for use in bio‑pharmacology: from research to production / A.V. Deykin [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №4.-P. 11-27. - Doi: 10.3897/rrpharmacology.7.76685. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46658 | - |
| dc.description.abstract | In this review, the analysis of technologies for obtaining biologically active proteins from various sources is carried out, and the comparative analysis of technologies for creating producers of biologically active proteins is presented. Special attention is paid to genetically modified animals as bioreactors for the pharmaceutical industry of a new type. The necessity of improving the technology of development transgenic rabbit producers and creating a platform solution for the production of biological products is substantiated | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | genetically modified animals | ru |
| dc.subject | recombinant protein | ru |
| dc.subject | biopharmacology | ru |
| dc.subject | foreign genes | ru |
| dc.subject | milk | ru |
| dc.subject | rabbits | ru |
| dc.title | Genetically modified animals for use in bio‑pharmacology: from research to production | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 7, № 4
|
